Cefaly^® DUAL is a neurostimulator for the non-pharmacological treatment of migraine.

It can be used

• as a preventive treatment to reduce the number of migraine attacks and
• as an abortive treatment to stop a migraine attack

Several clinical studies have proven the efficacy^1,2 and safety³ of Cefaly^®. Using Cefaly^® reduces the intake of anti-migraine drugs, thus limiting the risk of medication-overuse headache⁴.

Cefaly is a certified medical device, designed and manufactured according to current ISO standards.

References :
¹ Neurology 2013: Schoenen, J. Migraine prevention with a supraorbital transcutaneous stimulator: A randomized controlled trail.
² Cephalalgia 2018 : Chou, D. Acute migraine therapy with external trigeminal neurostimulation (ACME): a randomized controlled trail.
³ Journal of Headache and Pain 2013: Magis, D. Safety and patients' satisfaction of transcutaneous supraorbital neurostimulation (t-SNS) with the Cefaly^® device in headache treatment: a survey of 2, 313 headache sufferers in the general population.
⁴ Acta Neurol Belg. 2017: Penning, S. A survey on migraine attack treatment with the Cefaly^® device in regular users.

For more information and if you wish to try Cefaly, please visit www.cefaly.ch
You can also view there a video on the functionality of Cefaly DUAL.